Trident Labs, Inc. is a trailblazing high complexity toxicology laboratory established in 2014. Specializing in Pain Management Medication Monitoring drug testing, the company operates in the Biotechnology and Healthcare sectors, with its headquarters based in the United States.
With the slogan "A team with a vision to improve the clinical & environmental lab space through quality, creativity, & collaboration," Trident Labs embodies innovation and excellence in its field.
The Private Equity Round investment received by Trident Labs on 30 September 2019 was a significant milestone for the company, with Keiretsu Capital showing confidence in its potential for growth and impact in the industry.
Trident Labs' commitment to improving the clinical and environmental lab space shines through its dedication to quality, creativity, and collaboration. This ethos, combined with the recent investment, positions the company as a compelling prospect for venture capital firms seeking opportunities in the biotechnology and healthcare sectors.
No recent news or press coverage available for Trident Labs, Inc..